Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

J&J's New Reusable Contact Lens Promises Superior Comfort Through Full 2-Week Cycle

10 September 2026 · By · Wire by Fusion42

Published

10 September 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

Europe

◆ Source

Read at mddionline.com →

◆ Verified

Fusion42 · 10 September 2026 · Fusion42 review

Johnson & Johnson has received CE mark approval for its Acuvue Oasys Max 2-Week reusable contact lens, which offers advanced comfort and clarity technologies. The lens will launch in select European markets in late 2026 with broader rollout in 2027, but it lacks FDA approval for the US.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

Optometrists and eye-care startups in Europe now have a new high-tech reusable lens to recommend or build on, creating opportunities to enhance patient comfort and compete on advanced features. Your chance to differentiate with superior blue-light protection and moisture retention just expanded.

◆ Coverage

1 source · 10 Sep 2026

◆ Related on Wire

◆ Topics

Medtechcontact-lensesmedtechproduct-launcheye-carereusable-lenses